Potent antitumor activity of ensartinib in MET exon 14 skipping-mutated non-small cell lung cancer.
Xia Y, Jin R, Li M, Lan F, Zhu H, Yu Y, Miao D, Wang Q, Zhou Y, Selvaggi G, Ying S, Zhang J, Shen H, Le X, Li W.
Xia Y, et al. Among authors: ying s.
Cancer Lett. 2023 May 1;561:216140. doi: 10.1016/j.canlet.2023.216140. Epub 2023 Mar 21.
Cancer Lett. 2023.
PMID: 36948240
Free article.